Tenet Healthcare (NYSE:THC) Trading Up 7.3% – What’s Next?

Tenet Healthcare Corporation (NYSE:THC)’s stock price shot up 7.3% on Thursday . The company traded as high as $205.73 and last traded at $205.1840. 560,331 shares traded hands during mid-day trading, a decline of 55% from the average session volume of 1,240,793 shares. The stock had previously closed at $191.20.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on THC. TD Cowen lowered their price target on shares of Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating for the company in a research report on Monday, June 22nd. Wall Street Zen downgraded shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 11th. Royal Bank Of Canada lowered their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a report on Friday, May 1st. Guggenheim cut their price target on Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Finally, KeyCorp lowered their price objective on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Eighteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $244.32.

Tenet Healthcare Stock Performance

The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The firm has a market capitalization of $17.60 billion, a P/E ratio of 10.62, a price-to-earnings-growth ratio of 1.68 and a beta of 1.27. The business’s 50 day simple moving average is $181.48 and its two-hundred day simple moving average is $197.31.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The firm had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.39 billion. During the same quarter in the prior year, the company posted $4.36 earnings per share. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Sell-side analysts anticipate that Tenet Healthcare Corporation will post 17.61 EPS for the current fiscal year.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, Director Nadja West sold 3,000 shares of the business’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the transaction, the director owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. The trade was a 10.79% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director J Robert Kerrey sold 5,638 shares of the firm’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the sale, the director directly owned 16,804 shares in the company, valued at approximately $2,932,634.08. The trade was a 25.12% decrease in their position. The SEC filing for this sale provides additional information. 0.97% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Triumph Capital Management bought a new stake in Tenet Healthcare in the 3rd quarter worth approximately $25,000. Activest Wealth Management purchased a new position in shares of Tenet Healthcare in the 4th quarter worth $26,000. Elyxium Wealth LLC bought a new stake in shares of Tenet Healthcare in the fourth quarter worth $29,000. Meeder Asset Management Inc. lifted its holdings in Tenet Healthcare by 146.2% in the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after acquiring an additional 114 shares during the period. Finally, Canada Pension Plan Investment Board purchased a new position in Tenet Healthcare in the second quarter worth about $35,000. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.